Improving photocatalytic efficiency of MnFe2O4 ferrites via doping with Zn2+/La3+ ions: photocatalytic dye degradation for water remediation.

The interference of industrial effluents such as dyes, surfactants, metals, polycyclic aromatic hydrocarbons, and pharmaceutical waste has become a severe global problem for human health due to their carcinogenic, mutagenic, and toxic properties. Ferrites were considered promising photocatalysts for the degradation of organic and inorganic dyes. This study mainly focused on improving the photocatalytic performance of MnFe2O4 nanoferrites via doping of Zn2+ and La3+ ions. The zinc and lanthanum substituted Mn1-xZnxLayFe2-yO4 nanoferrites were prepared by the sol-gel auto-combustion technique for the degradation of organic textile malachite green dye (MGD) under the natural solar irradiation. The synthesized nanoferrites were investigated for their structural properties, surface morphology and elemental analysis, optical studies, magnetic properties, and photocatalytic performance by XRD, FESEM/EDX, FTIR/Raman spectrum, vibrating sample magnetometer, and UV-visible spectrophotometer, respectively. The substitution of zinc and lanthanum improved the photocatalytic efficiency of nanoferrites, and about 96% of MGD was degraded by Mn0.97Zn0.03La0.04Fe1.96O4 after 60 min of irradiation. The results showed the pseudo-first-order kinetics for dye degradation using undoped and Zn/La-doped MnFe2O4 photocatalysts.

Robust and sustainable Mg1-xCexNiyFe2-yO4 magnetic nanophotocatalysts with improved photocatalytic performance towards photodegradation of crystal violet and rhodamine B pollutants.

This study aims at manufacturing Ce3+/Ni2+ ions doped Mg nanoferrites by the sol-gel method for the photocatalytic degradation of rhodamine B and crystal violet pollutants under visible natural sunlight. The particle size of synthesized nanoferrites was calculated through XRD, Hall-William plots, and TEM analysis, which perfectly agree with each other. FTIR study investigated the existence of stretching vibrations in M - O (metal-oxygen) complexes at the tetrahedral (A-site) and octahedral sites (B-site). The Raman spectra of synthesized nanophotocatalysts show the presence of four vibrational modes (Eg + 2T2g + A1g), providing suitable information of occupancy of Mg2+, Ce3+, Ni2+, and Fe3+ ions at the interstitial sites of undoped and Ce3+/Ni2+ doped MgFe2O4 crystal structure. The synthesized MGF3 nanophotocatalyst performs well with degradation of 97.674% crystal violet (CV) and 90.05% rhodamine B (RhB) under natural sunlight in 60 min. The experimental results showed that doped MgFe2O4 nanoferrites have a high tendency to photodegrade the RhB and CV dyes in an aqueous form. The pseudo-first-order equation reflects the best photocatalytic process kinetics and studied the feasibility of RhB and CV dyes adsorption on the doped and undoped MgFe2O4 nanoferrites. The results show good support for adsorption by the spontaneous photodegradation process. The excellent photocatalytic activity of synthesized nanoferrites under natural sunlight verifies them as a potential candidate for the photodegradation of organic dyes. Finally, the antibacterial activity of magnetic nanoferrites was examined against S. aureus and E. Coli. The studies demonstrated that synthesized magnetic nanoferrites were more effective against S. aureus.

Challenges and Recent Advances of Novel Chemical Inhibitors in Medulloblastoma Therapy.

Medulloblastoma is a common term used for the juvenile malignant brain tumor, and its treatment is exciting due to different genetic origins, improper transportation of drug across the blood-brain barrier, and chemo-resistance with various side effects. Currently, medulloblastoma divided into four significant subsections (Wnt, Shh, Group 3, and Group 4) is based on their hereditary modulation and histopathological advancement. In this chapter, we tried to combine several novel chemical therapeutic agents active toward medulloblastoma therapy. All these compounds have potent activity to inhibit the medulloblastoma.